Loading the security page…
A security analysis is not yet prepared for this market.
The next payment has not been announced
Oramed Pharmaceuticals Inc. (ORMP) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Oramed Pharmaceuticals Inc. (ORMP) on November 10, 2026 is 3.97 $, −0.75 % on the day. Over 52 weeks the stock traded between 2.09 $ and 5.47 $; the price now sits 56 % of the way up that range. Over the past year the price changed by +67.36 %. The P/E ratio is 0.95, which is below the sector median (25.57). Market capitalization is 165.26 million $, rank 207 among 380 stocks of the same industry with a known capitalization.
Oramed Pharmaceuticals Inc. trades on Nasdaq under the ticker ORMP. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks ORMP has traded between 2.09 $ and 5.47 $. As of 10 November 2026 the price stood 56.51% of the way from the 52-week low to the high.
Over one year ORMP shares rose 67.36%; over six months they rose 1.78%. Volatility over 90 days is 41.12%. Dividends are not included: this is price change only, as of 10 November 2026.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
ORMP trades at a price-to-earnings ratio of 0.9, below the sector median of 25.6. Price to sales is 82.6, above the sector median of 3.7. Price to book is 0.5, below the sector median of 2.4. Calculated from reports for the period ending 30 June 2026.
Oramed Pharmaceuticals Inc. reported revenue of 2M $ and net income of 175M $ over the last four quarters. Revenue changed by +49.25% year over year. Earnings per share are $4.13. Market capitalisation is 165M $.
ORMP has a return on equity of 55.08%, above the sector median of −40.58%. Return on assets is 47.31%, above the sector median of −30.08%.
Oramed Pharmaceuticals Inc. pays dividends: 0.25 $ per share over the past twelve months, a yield of 6.25%. The latest payment was 0.25 $, with an ex-dividend date of 16 January 2026.